SOURCE: NutraCea

August 17, 2011 08:00 ET

DSM and NutraCea Announce Joint Research Program Targeting Rice Bran Derived Protein

URMOND, THE NETHERLANDS and SCOTTSDALE, AZ--(Marketwire - Aug 17, 2011) - The DSM Innovation Center ('DSM') and NutraCea (OTCQB: NTRZ) (PINKSHEETS: NTRZ) announce that on August 15, 2011, the companies entered into a Joint Research and Development Agreement ('JDA'). Under the terms of the agreement, NutraCea and DSM will share existing patented and proprietary intellectual property and know-how to investigate extraction and modification of high quality vegetable proteins from rice bran.

DSM's Remco van Es, Business Manager Food & Feed Segment, commented: "After our initial analysis of climate change impacts on global agricultural output in the context of a growing world population, we realized that mining for food components like proteins from vegetable agricultural side streams or biorefineries could play an important role as part of a solution. Furthermore, when it comes to the nitrogen cycle our planet's sustainable limits have already been exceeded by at least 200%. It is only logical to investigate possibilities to harvest protein from currently underdeveloped sources like rice bran."

Rob van Leen, Chief Innovation Officer at DSM, adds: "While we fully realize that the world will continue to need animal derived proteins, we believe it is important to explore ways of extracting proteins from plant material, and we aim to make a contribution in this area. NutraCea's management team, headed by John Short and Leo Gingras, have restructured their company to focus only on rice bran derived products and rice bran bio-refining. Their proprietary and patented technologies and expertise in the field of rice bran combined with DSM's technology base in bio-based products form the perfect platform to tackle this plant-based protein challenge. This project fits extremely well within our sustainability and innovation focus at DSM."

NutraCea's Chief Executive Officer, W. John Short, commented: "This Joint Research and Development Agreement between DSM and NutraCea provides the opportunity for our two companies to join forces in the development and potential commercialization of protein from rice bran targeted to human food and ingredient applications. To feed a growing world population, additional alternative sources of protein will become increasingly important. The intrinsic product characteristics of rice bran -- hypoallergenic, gluten free, full range of amino acids, and easy digestibility leading to high bioavailability -- can serve as a valuable additional protein source for our growing world population. In that context, working together with DSM provides the opportunity for our two companies to take advantage of an underutilized co-product of an existing resource -- rice bran -- obtained from the existing global rice crop as a sustainable and renewable protein source that requires no additional land or water resources. We appreciate the opportunity to collaborate with the people at DSM. Their corporate commitment to sustainability and renewability, as reflected in their philosophy and vision of 'people, planet and profit,' are values that we share at NutraCea. We look forward to working with the DSM team."

Additional information regarding the JDA is included in the Form 8-K filed with the United States Securities and Exchange Commission on the date hereof.

DSM - Bright Science. Brighter Living.™

DSM Innovation Center is part of Royal DSM N.V., a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

About NutraCea

NutraCea is a world leader in production and marketing of stabilized rice bran (SRB), rice bran oil (RBO) and their derivative products. NutraCea holds many patents for stabilized rice bran (SRB) production technology and proprietary products derived from SRB. NutraCea's proprietary technology enables the creation of nutritional and functional food products from rice bran, normally an underutilized co-product of rice milling. More information can be found in the Company's filings with the SEC and by visiting our website at www.NutraCea.com.

Forward-looking statements DSM

This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Forward-Looking Statements NutraCea

This release contains forward-looking statements, including statements about (i) the potential to commercialize protein from rice bran and rice products and (ii) provide a sustainable source of protein for the food industry, (iii) the growing need for larger volumes of high quality digestible protein, and (iv) the ability of DSM's technology base and NutraCea's expertise to provide a platform to address and commercialize the rice protein area. These statements are made based upon current expectations that are subject to risk and uncertainty. NutraCea (the company) does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the company's filings with the Securities and Exchange Commission, including the company's most recent periodic reports.

Contact Information

  • For more information:
    DSM Innovation Center
    Remco van Es - Program Manager
    T: +31 (0) 46 4763175
    M: +31 (0) 6102 72801
    E: Email Contact

    NutraCea Investor Contact:
    Alliance Advisors, LLC
    Alan Sheinwald
    President
    Email Contact
    Tel: (914) 669-0222